Family · Pharmaceutical analytical standards
Buspirone
An anxiolytic of the azapirone class that acts mainly on serotonin 5-HT1A receptors: synthesised in 1968 and approved in the United States in 1986 for generalised anxiety disorder. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It was born as an antipsychotic, designed to act on dopamine D2 receptors: it proved ineffective against psychosis and was repurposed to treat anxiety.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
